. Overview We are a clinical-stage biotechnology company committed to a bold mission: to discover, develop and deliver potentially curative therapies that address the underlying drivers of heart disease. Heart disease remains the leading cause of death in the world. In the U.S., one person dies from a cardiovascular-related health condition every 34 seconds, a gruesome statistic that translates to one in every three deaths in the U.S each year. One in 20 adults suffer from congenital heart disea...
Q2 FY2026 — expected 2026-08-05
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-11 | 2025-12-31 | 0001193125-26-102252 | EDGAR | 95K words |
| 2025-03-10 | 2024-12-31 | 0000950170-25-036329 | EDGAR | — |
| 2024-03-18 | 2023-12-31 | 0000950170-24-032828 | EDGAR | — |
| 2023-03-08 | 2022-12-31 | 0000950170-23-006725 | EDGAR | — |
| 2022-03-23 | 2021-12-31 | 0000950170-22-004426 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-10 | 2025-09-30 | 0001193125-25-273239 | EDGAR | 61K words |
| 2025-08-06 | 2025-06-30 | 0000950170-25-104182 | EDGAR | — |
| 2025-05-07 | 2025-03-31 | 0000950170-25-065741 | EDGAR | — |
| 2024-11-06 | 2024-09-30 | 0000950170-24-122359 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0000950170-24-094059 | EDGAR | — |
| 2024-05-14 | 2024-03-31 | 0000950170-24-059576 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0000950170-23-061162 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0000950170-23-040651 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0000950170-23-020609 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0000950170-22-024521 | EDGAR | — |
| 2022-08-10 | 2022-06-30 | 0000950170-22-016478 | EDGAR | — |
| 2022-05-11 | 2022-03-31 | 0000950170-22-009363 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-11 | 0001193125-26-102170 | EDGAR | 3K words |
| 2026-03-05 | 0001193125-26-092654 | EDGAR | — |
| 2026-01-30 | 0001193125-26-032017 | EDGAR | — |
| 2026-01-02 | 0001193125-26-001065 | EDGAR | — |
| 2025-12-12 | 0001193125-25-317642 | EDGAR | — |
| 2025-12-11 | 0001193125-25-315951 | EDGAR | — |
| 2025-11-10 | 0001193125-25-273230 | EDGAR | — |
| 2025-11-07 | 0001193125-25-272423 | EDGAR | — |
| 2025-08-06 | 0000950170-25-104164 | EDGAR | — |
| 2025-05-30 | 0000950170-25-079773 | EDGAR | — |
83 total filings indexed. 56 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001858848 |
| Ticker | TNYA |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.tenayatherapeutics.com |
| Listed | 2021-07-30 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report